{"id":"https://genegraph.clinicalgenome.org/r/1bfed823-4cad-4a16-93d5-ba5910348902v1.0","type":"EvidenceStrengthAssertion","dc:description":"Pathogenic variants in the PURA gene were initially reported in relation to autosomal dominant PURA syndrome, a complex neurodevelopmental disorder, in 2014 (Lalani et al. PMID: 25439098). At least 50 unique variants variants (e.g. missense, in-frame indel, nonsense, frameshift, large deletions) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data.\n\nMore evidence is available in the literature, but the maximum score for genetic evidence and\nexperimental evidence (12 pts.) has been reached.\n\nIn summary, PURA is definitively associated with an autosomal dominant complex neurodevelopmental disorder.\nThis has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/1bfed823-4cad-4a16-93d5-ba5910348902","GCISnapshot":"https://genegraph.clinicalgenome.org/r/6819633c-e488-4856-8dec-3981cd14db9b","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/6819633c-e488-4856-8dec-3981cd14db9b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2018-12-18T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/6819633c-e488-4856-8dec-3981cd14db9b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6819633c-e488-4856-8dec-3981cd14db9b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6819633c-e488-4856-8dec-3981cd14db9b_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/35cb04df-55af-47bf-8be1-754e81a7bc9f","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b9abceb-cbe6-496c-adf0-0d336eb721fb","type":"Finding","dc:description":"Pura -/- mice exhibit a phenotype with delayed development and slow growth, continuous tremor, ataxia, and premature death. The phenotype overlaps with the complex neurodevelopmental disorder in humans characterized by dev delay, seizures, a movement disorder including ataxia, and tremor has been reported in a small number of patients.  The Pura +/- mice were noted to have spontaneous seizures when they were handled.  Histopathological analysis showed lower numbers of neurons in regions of the hippocampus and cerebellum of PURA-/- mice, Evaluation of brain sections indicated a reduction in myelin in oligodendrocytes and glial fibrillary acidic protein labeling in astrocytes","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12972605","rdfs:label":"PURA gene inactivation in PURA-/- and PURA +/- mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fa79a741-48f3-4ac3-bcd1-2ecb1e1b9379","type":"EvidenceLine","dc:description":"Knockout mouse model has phenotype similar to what is reported in prior publication, supporting the findings in Khalili et al., 2003.  However, they did not make a +/- model in this publication so will not add any additional points for this model per discussion with Epilepsy Gene Curation group.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5133d690-d063-4173-97cc-75ce05ce3e49","type":"Finding","dc:description":"Pura -/- mice were able to be bred until adulthood in this study, but they died prematurely at 5-6 months and adult Pura-deficient mice exhibited continuous tremor, ataxia, and enlarged brain size.  In humans, the phenotype consists of a complex neurodevelopmental disorder with dev delay, seizures, and a movement disorder including ataxia, and tremor has been reported in a small number of patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22010047","rdfs:label":"Pura-deficient mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/6819633c-e488-4856-8dec-3981cd14db9b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b266678-acd0-4d46-82ec-7278ccac1f37","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cbedb587-9fd7-4612-ae6e-e40d5987b598","type":"Finding","dc:description":"FMR1 causes fragile X syndrome (FXS), a complex neurodevelopmental disorder that causes intellectual disability, autism spectrum disorder, and behavioral issues, as well as FXTAS which is a neurodegenerative disorder causing ataxia and tremor, so features of FXS and FXTAS overlap with PURA. This experiment used a double-chromatin immunoprecipitation method using mouse brain tissue that has been fixed with a cross-linking agent to determine whether the RNA and both proteins being studied are bound in vivo.  After immunoprecipitation, cross-linking is reversed, and RNA is detected by RT-PCR.  Results indicate that Pura colocalizes in dendrites with proteins implicated previously in dendritic transport or translation, including FMRP as well as Staufen, and it also coimmunoprecipitates with these proteins on both non-coding BC1 RNA and Map1B and Map2 mRNAs. Pura is localized at sites of dendritic mRNA translation and colocalized with FMRP at multiple small foci throughout dendrites.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16511857","rdfs:label":"Pur alpha interacts with FMRP","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5},{"id":"https://genegraph.clinicalgenome.org/r/6819633c-e488-4856-8dec-3981cd14db9b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6819633c-e488-4856-8dec-3981cd14db9b_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ace61c82-3077-443c-8457-9b707fac04f2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"De novo variant with confirmed parentage identified by exome sequencing","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0112058c-8257-43d6-a021-eccdb9230bf5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25439098","rdfs:label":"Subject 1","ageType":"AgeAtReport","ageUnit":"Months","ageValue":6,"detectionMethod":"Clinical exome sequencing performed at Baylor College of Medicine.  Confirmed by Sanger sequencing.  Parents tested by Sanger and evaluation of rare linked markers confirmed parentage.","ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0007334","obo:HP_0011968","obo:HP_0001263","obo:HP_0008947","obo:HP_0002098","obo:HP_0002123","obo:HP_0001250","obo:HP_0010818"],"previousTesting":true,"previousTestingDescription":"SMA, Prader-Willi syndrome, Plasma amino acids, Urine organic acids, Chromosomal microarray all non-diagnostic","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ace61c82-3077-443c-8457-9b707fac04f2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25439098","allele":{"id":"https://genegraph.clinicalgenome.org/r/7774df7b-cbf4-4b1e-8a7b-66bc698ab5f6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005859.4(PURA):c.812_814delTCT (p.Phe271del)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/156403"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/8912fcce-8221-42cb-8764-b48a02b3d45b_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/447193a5-8583-47cb-8136-f7f44021b9dc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29097605","rdfs:label":"Patient 15","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"detectionMethod":"Trio WES: DNA samples from patients and their parents were analysed by the Wellcome Trust Sanger Institute through the Deciphering Developmental Disorders (DDD) research study","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002194","obo:HP_0008947","obo:HP_0002098","obo:HP_0001344","obo:HP_0010864","obo:HP_0007359","obo:HP_0002376","obo:HP_0005964"],"previousTesting":true,"previousTestingDescription":"array CGH 11q21 del (mat) benign CNV.  Fragile X, Alan-Hearndon-Dudley, POLG, PWS, SMN, mtDNA deletions, amino acids, organic aciods, acylcarnitine, mucopoly and oligosaccharide screen.lysosomal enzymes, VLCFAs, biotinidase, transferin isoelectric focusing all non-diagnostic.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8912fcce-8221-42cb-8764-b48a02b3d45b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29097605","allele":{"id":"https://genegraph.clinicalgenome.org/r/416ceff2-9564-4da1-b018-a094e894847c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005859.4(PURA):c.734G>C (p.Arg245Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/545025"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/df9ac201-8af0-44a0-9c0c-7786a6dbf0b3_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/adf05b85-73a3-4756-ac01-88317d37a34b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29097605","rdfs:label":"Patient 4","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"detectionMethod":"Whole exome sequencing (WES) was performed in individuals with ID in a diagnostic setting. No further details provided.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002104","obo:HP_0012448","obo:HP_0008947","obo:HP_0001344","obo:HP_0002098","obo:HP_0000729","obo:HP_0010864","obo:HP_0011968"],"previousTesting":true,"previousTestingDescription":"Prader-Willi syndrome, PHOX2B not diagnostic, Delayed decreased motor and sensore conduction (age 6 months) on peripheral nervous testing, normal lumbar puncture","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/df9ac201-8af0-44a0-9c0c-7786a6dbf0b3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29097605","allele":{"id":"https://genegraph.clinicalgenome.org/r/14a25906-8389-458b-b13e-7acc891cd3b6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005859.4(PURA):c.697_699delTTC (p.Phe233del)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/189319"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/336026bd-8318-4c32-af51-7193aff08c2d_proband_score_evidence_line","type":"EvidenceLine","dc:description":"de novo variant with confirmed parentage identified by exome sequencing","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/45a5a376-c862-4817-81bd-f95c64b4d9f0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29150892","rdfs:label":"DB13- 043","ageType":"AgeAtReport","ageUnit":"Years","ageValue":5,"detectionMethod":"Research whole exome sequencing performed on saliva-derived DNA from proband and both parents, using the Agilent Sure-Select 50 Mb whole exome capture kit.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0008947","obo:HP_0002079","obo:HP_0010535","obo:HP_0002020","obo:HP_0002019","obo:HP_0000639","obo:HP_0002500","obo:HP_0002104","obo:HP_0001263","obo:HP_0001250"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/336026bd-8318-4c32-af51-7193aff08c2d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29150892","allele":{"id":"https://genegraph.clinicalgenome.org/r/db9b13e0-ca83-41aa-a6e5-3d91370862c7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005859.4(PURA):c.596G>C (p.Arg199Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/156413"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/e0e124d5-abbd-4dee-a20f-e05b853ca4e2_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c9cf524-7017-49e8-9f6d-d14ed8b8e33b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29097605","rdfs:label":"Patient 5","ageType":"AgeAtReport","ageUnit":"Years","ageValue":19,"detectionMethod":"Whole exome sequencing (WES) was performed in individuals with ID in a diagnostic setting. No further details provided.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0012448","obo:HP_0001344","obo:HP_0002104","obo:HP_0008947","obo:HP_0002194","obo:HP_0002098","obo:HP_0011968","obo:HP_0200134","obo:HP_0000639","obo:HP_0010864","obo:HP_0002376","obo:HP_0002066"],"previousTesting":true,"previousTestingDescription":"MECP2, Prader-Willi, CDG syndrome, normal metabolic screening","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e0e124d5-abbd-4dee-a20f-e05b853ca4e2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29097605","allele":{"id":"https://genegraph.clinicalgenome.org/r/14a25906-8389-458b-b13e-7acc891cd3b6"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/373426c4-6317-4cee-bc5a-d517ace2a2fa_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/811e98dd-a2fe-46ac-9096-e325f72d16d4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29097605","rdfs:label":"Patient 9","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"detectionMethod":"Whole exome sequencing (WES) was performed in individuals with ID in a diagnostic setting. No further details provided.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002194","obo:HP_0001344","obo:HP_0002020","obo:HP_0002098","obo:HP_0010864","obo:HP_0002121","obo:HP_0011968","obo:HP_0008947"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/373426c4-6317-4cee-bc5a-d517ace2a2fa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29097605","allele":{"id":"https://genegraph.clinicalgenome.org/r/e32ab8e8-3baf-452c-bcda-27b36e40446a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005859.4(PURA):c.572C>T (p.Pro191Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/421477"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4f467441-77f9-4049-be40-58d1569b2a00_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8ca64bf7-7d0d-4b09-8f18-e8bdf4dab41e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29097605","rdfs:label":"Patient 27","ageType":"AgeAtReport","ageUnit":"Years","ageValue":15,"detectionMethod":"Whole exome sequencing (WES) was performed in individuals with ID in a diagnostic setting. No further details provided.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0010819","obo:HP_0011968","obo:HP_0002342","obo:HP_0008947","obo:HP_0001263"],"previousTesting":true,"previousTestingDescription":"MECP2, Angelman syndrome, UBE3A, Coffin-Lowry syndrome, RAI1, ZEB2, TCF4, CDKL5 all non-diagnostic.  Mild excess variation in fiber size. Peripheral nerve system testing suggestive for congenital myopathy. No generalized polyneuropathy.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4f467441-77f9-4049-be40-58d1569b2a00_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29097605","allele":{"id":"https://genegraph.clinicalgenome.org/r/8253033d-48a8-4488-9b43-94979bbc19c6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005859.4(PURA):c.711dupC (p.Asn238Glnfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/280894"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":12}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":529,"specifiedBy":"GeneValidityCriteria6","strengthScore":16.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/1SbnJZRRQnI","type":"GeneValidityProposition","disease":"obo:MONDO_0100038","gene":"hgnc:9701","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_6819633c-e488-4856-8dec-3981cd14db9b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}